Top

Published in:

01-11-2019 | Obesity | Clinical Study

Underweight and weight loss are predictors of poor outcome in patients with brain metastasis

Authors: Anna Lareida, Robert Terziev, Bettina Grossenbacher, Nicolaus Andratschke, Patrick Roth, Sabine Rohrmann, Rolf Stahel, Matthias Guckenberger, Emilie Le Rhun, Michael Weller, Fabian Wolpert

Published in: Journal of Neuro-Oncology | Issue 2/2019

Abstract

Purpose

Overweight may be associated with favorable outcome whereas tumor cachexia may be associated with worse outcome in patients with metastatic cancer. Here we evaluate the association of abnormal body mass index and weight change with outcome in patients with brain metastasis.

Methods

Patients with a diagnosis of brain metastasis treated at the University Hospital Zurich (n = 703) were assessed for associations of body mass index, weight change, comorbidities and survival.

Results

Compared with patients with normal body mass index of 18.5–24.9 kg/m² and a median overall survival of 9 months (95% confidence interval 7.5–10.5), overall survival was inferior in patients with body mass index < 18.5 kg/m² (overall survival 6 months, 95% confidence interval 1.6–10.3, p = 0.04), but superior in patients with body mass index > 25 kg/m² (overall survival 13 months, 95% confidence interval 11.0–15.0; p = 0.033). We report a median relative weight loss of 5% within the first 6 months of diagnosis of brain metastasis (95% confidence interval 3.3–6.5), and reduction exceeding the median was associated with an unfavorable outcome (weight loss < 5% 22.0 months, 95% confidence interval 19.2–24.8; weight loss > 5% 14.0 months, 95% confidence interval 11.9–16.).

Conclusion

High body mass index is associated with better, and underweight with worse outcome in patients with brain metastasis. Conversely, weight loss above median may predict poor outcome. Future studies need to address whether vigorous treatment of tumor cachexia, e.g. by specific nutrition management, might improve outcome of patients with brain metastasis. In contrast, regimens associated with weight loss such as ketogenic diet may be detrimental.

Available only for authorised users

Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW (2012) A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro-oncology 14:910–918. https://doi.org/10.1093/neuonc/nos087 CrossRefPubMedPubMedCentral

Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–14. https://doi.org/10.1007/s11060-004-8093-6 CrossRefPubMed

Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514. https://doi.org/10.1016/j.ijrobp.2007.06.074 CrossRefPubMed

Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL, Quesenberry CP, Kwan ML, Prado CM (2017) Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 26:1008–1015. https://doi.org/10.1158/1055-9965.EPI-17-0200 CrossRefPubMedPubMedCentral

Chen HN, Chen XZ, Zhang WH, Yang K, Chen XL, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK (2015) The impact of body mass index on the surgical outcomes of patients with gastric cancer: a 10-year single-institution cohort study. Medicine (Baltimore) 94:e1769. https://doi.org/10.1097/MD.0000000000001769 CrossRef

Dahlberg SE, Schiller JH, Bonomi PB, Sandler AB, Brahmer JR, Ramalingam SS, Johnson DH (2013) Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials. J Thorac Oncol 8:1121–1127. https://doi.org/10.1097/JTO.0b013e31829cf942 CrossRefPubMedPubMedCentral

Miao L, Chen H, Xiang J, Zhang Y (2015) A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy. J Cancer Res Clin Oncol 141:941–950. https://doi.org/10.1007/s00432-014-1878-x CrossRefPubMed

Tsang NM, Pai PC, Chuang CC, Chuang WC, Tseng CK, Chang KP, Yen TC, Lin JD, Chang JT (2016) Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med 5:665–675. https://doi.org/10.1002/cam4.634 CrossRefPubMedPubMedCentral

Chen MJ, Wu WY, Yen AM, Fann JC, Chen SL, Chiu SY, Chen HH, Chiou ST (2016) Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women. Int J Obes (Lond) 40:524–530. https://doi.org/10.1038/ijo.2015.205 CrossRef

10.

Cleary MP, Grossmann ME (2009) Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 150:2537–2542. https://doi.org/10.1210/en.2009-0070 CrossRefPubMedPubMedCentral

11.

Jones LW, Ali-Osman F, Lipp E, Marcello JE, McCarthy B, McCoy L, Rice T, Wrensch M, Il'yasova D (2010) Association between body mass index and mortality in patients with glioblastoma mutliforme. Cancer Causes Control 21:2195–2201. https://doi.org/10.1007/s10552-010-9639-x CrossRefPubMedPubMedCentral

12.

Chambless LB, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC (2012) Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma. J Neurooncol 106:383–389. https://doi.org/10.1007/s11060-011-0676-4 CrossRefPubMed

13.

Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM (2013) Prediagnostic body weight and survival in high grade glioma. J Neurooncol 114:79–84. https://doi.org/10.1007/s11060-013-1150-2 CrossRefPubMedPubMedCentral

14.

Masel EK, Berghoff AS, Fureder LM, Heicappell P, Schlieter F, Widhalm G, Gatterbauer B, Dieckmann U, Birner P, Bartsch R, Schur S, Watzke HH, Zielinski CC, Preusser M (2017) Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: a retrospective analysis of 624 patients. Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.12707 CrossRef

15.

Bjorntorp P (1991) Metabolic implications of body fat distribution. Diabetes Care 14:1132–1143CrossRef

16.

Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 8:29. https://doi.org/10.1186/1478-7954-8-29 CrossRefPubMedPubMedCentral

17.

Akin I, Nienaber CA (2015) "Obesity paradox" in coronary artery disease. World J Cardiol 7:603–608. https://doi.org/10.4330/wjc.v7.i10.603 CrossRefPubMedPubMedCentral

18.

Andersen KK, Olsen TS (2015) The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke 10:99–104. https://doi.org/10.1111/ijs.12016 CrossRefPubMed

19.

Dehlendorff C, Andersen KK, Olsen TS (2014) Body mass index and death by stroke: no obesity paradox. JAMA Neurol 71:978–984. https://doi.org/10.1001/jamaneurol.2014.1017 CrossRefPubMed

20.

Klement RJ (2017) Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. Med Oncol 34:132. https://doi.org/10.1007/s12032-017-0991-5 CrossRefPubMed

21.

Rieger J, Bahr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kammerer U, Coy JF, Weller M, Steinbach JP (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44:1843–1852. https://doi.org/10.3892/ijo.2014.2382 CrossRefPubMedPubMedCentral

Title: Underweight and weight loss are predictors of poor outcome in patients with brain metastasis
Authors: Anna Lareida
Robert Terziev
Bettina Grossenbacher
Nicolaus Andratschke
Patrick Roth
Sabine Rohrmann
Rolf Stahel
Matthias Guckenberger
Emilie Le Rhun
Michael Weller
Fabian Wolpert
Publication date: 01-11-2019
Publisher: Springer US
Keywords: Obesity
Obesity
Metastasis
Underweight
Underweight
Overweight
Arterial Hypertension
Arterial Hypertension
Published in: Journal of Neuro-Oncology / Issue 2/2019
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-019-03300-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Underweight and weight loss are predictors of poor outcome in patients with brain metastasis

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2019

Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma

Fatal encephalopathy after pembrolizumab treatment for advanced non-small cell lung carcinoma

Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells

Risk factors for intraoperative stimulation-related seizures during awake surgery: an analysis of 109 consecutive patients

Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas

Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imaging